Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Molecular Partners AG
Description Designed ankyrin repeat protein (DARPin) that inhibits VEGF and HGF
Molecular Target Vascular endothelial growth factor (VEGF) ; Hepatocyte growth factor/scatter factor (HGF/SF)
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today